Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Landgren

Showing results (321-330 of 519) with videos related to

Pageof 52
Sort By:
Bone Marrow Transplantation|May 6, 2018
Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myelomaNishant Tageja, Neha Korde, Dickran Kazandjian, et al.
Journal of the National Cancer Institute|September 21, 2006
Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in ScandinaviaOla Landgren, Eric A Engels, Ruth M Pfeiffer, et al.
Cancer Cell|April 2, 2013
Control of autophagic cell death by caspase-10 in multiple myelomaLaurence Lamy, Vu N Ngo, N C Tolga Emre, et al.
Haematologica|July 18, 2009
Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based studySigurdur Y Kristinsson, Magnus Björkholm, Therese M-L Andersson, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 18, 2019
Immune Signatures Associated With Clonal Isotype Switch After Autologous Stem Cell Transplantation for Multiple MyelomaRebecca Ye, Sirisha Kundrapu, Stanton L Gerson, et al.
European Journal of Haematology|December 9, 2020
Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significanceTheodóra Rún Baldursdóttir, Þorvarður Jón Löve, Gauti Kjartan Gíslason, et al.
Leukemia & Lymphoma|August 7, 2013
Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphomaElisabet E Manasanch, Raul Braylan, Maryalice Stetler-Stevenson, et al.
British Journal of Haematology|November 21, 2007
Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesisMartha S Linet, Mary K Schubauer-Berigan, Dennis D Weisenburger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2015
Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based StudyMalin Hultcrantz, Sally R Wilkes, Sigurdur Y Kristinsson, et al.
Blood|October 16, 2009
Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective studyHuei-Ting Tsai, Neil E Caporaso, Robert A Kyle, et al.
Pageof 52

Showing results (321-330 of 519) with videos related to

Sort By:
Pageof 52
Bone Marrow Transplantation|May 6, 2018
Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myelomaNishant Tageja, Neha Korde, Dickran Kazandjian, et al.
Journal of the National Cancer Institute|September 21, 2006
Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in ScandinaviaOla Landgren, Eric A Engels, Ruth M Pfeiffer, et al.
Cancer Cell|April 2, 2013
Control of autophagic cell death by caspase-10 in multiple myelomaLaurence Lamy, Vu N Ngo, N C Tolga Emre, et al.
Haematologica|July 18, 2009
Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based studySigurdur Y Kristinsson, Magnus Björkholm, Therese M-L Andersson, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 18, 2019
Immune Signatures Associated With Clonal Isotype Switch After Autologous Stem Cell Transplantation for Multiple MyelomaRebecca Ye, Sirisha Kundrapu, Stanton L Gerson, et al.
European Journal of Haematology|December 9, 2020
Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significanceTheodóra Rún Baldursdóttir, Þorvarður Jón Löve, Gauti Kjartan Gíslason, et al.
Leukemia & Lymphoma|August 7, 2013
Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphomaElisabet E Manasanch, Raul Braylan, Maryalice Stetler-Stevenson, et al.
British Journal of Haematology|November 21, 2007
Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesisMartha S Linet, Mary K Schubauer-Berigan, Dennis D Weisenburger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2015
Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based StudyMalin Hultcrantz, Sally R Wilkes, Sigurdur Y Kristinsson, et al.
Blood|October 16, 2009
Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective studyHuei-Ting Tsai, Neil E Caporaso, Robert A Kyle, et al.
Pageof 52